ATE175870T1 - Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen - Google Patents

Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen

Info

Publication number
ATE175870T1
ATE175870T1 AT94105352T AT94105352T ATE175870T1 AT E175870 T1 ATE175870 T1 AT E175870T1 AT 94105352 T AT94105352 T AT 94105352T AT 94105352 T AT94105352 T AT 94105352T AT E175870 T1 ATE175870 T1 AT E175870T1
Authority
AT
Austria
Prior art keywords
rectal administration
active compounds
pharmaceutical preparation
pharmacologically active
gelatine
Prior art date
Application number
AT94105352T
Other languages
English (en)
Inventor
Luc Grislain
Huede Elisabeth Le
Oliver Louis
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of ATE175870T1 publication Critical patent/ATE175870T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A61K9/025—Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
AT94105352T 1993-04-13 1994-04-07 Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen ATE175870T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9304323A FR2703908B1 (fr) 1993-04-13 1993-04-13 Forme pharmaceutique pour administration rectale de composés pharmacologiquement actifs.

Publications (1)

Publication Number Publication Date
ATE175870T1 true ATE175870T1 (de) 1999-02-15

Family

ID=9446005

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94105352T ATE175870T1 (de) 1993-04-13 1994-04-07 Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen

Country Status (9)

Country Link
US (1) US5433958A (de)
EP (1) EP0624365B1 (de)
JP (1) JP3813185B2 (de)
AT (1) ATE175870T1 (de)
DE (1) DE69416034T2 (de)
DK (1) DK0624365T3 (de)
ES (1) ES2127305T3 (de)
FR (1) FR2703908B1 (de)
GR (1) GR3029916T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730691B1 (en) 2000-02-10 2004-05-04 Miles A. Galin Uses of alpha adrenergic blocking agents
US8394397B2 (en) * 2003-03-28 2013-03-12 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Adhesive antineoplastic compositions
US11013831B2 (en) 2019-02-20 2021-05-25 Warsaw Orthopedic, Inc. Methods of synthesis for a thioketal diol

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
US4406896A (en) * 1979-12-20 1983-09-27 Merck & Co., Inc. Adjuvants for rectal delivery of drug substances
GB2077691B (en) * 1980-06-05 1983-11-02 Shinetsu Chemical Co Medicament capsules for rectal administration
EP0137364A3 (de) * 1983-09-23 1986-10-22 Merck & Co. Inc. Suppositoriumsform eines osmotischen therapeutischen Systems
EP0147479A1 (de) * 1983-12-23 1985-07-10 Merck & Co. Inc. Wasser und Medikament lieferndes System zur Verwendung als Suppositorium
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
GB2196252B (en) * 1986-09-18 1990-10-17 London Pharmacy Innovation Gastric controlled-release dosage forms
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
US5182270A (en) * 1989-08-03 1993-01-26 Iolab Corporation Stabilizing preparation for thymoxamine

Also Published As

Publication number Publication date
DK0624365T3 (da) 1999-09-13
EP0624365A1 (de) 1994-11-17
GR3029916T3 (en) 1999-07-30
FR2703908A1 (fr) 1994-10-21
JPH072646A (ja) 1995-01-06
DE69416034D1 (de) 1999-03-04
FR2703908B1 (fr) 1995-06-02
JP3813185B2 (ja) 2006-08-23
DE69416034T2 (de) 1999-06-17
US5433958A (en) 1995-07-18
ES2127305T3 (es) 1999-04-16
EP0624365B1 (de) 1999-01-20

Similar Documents

Publication Publication Date Title
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
SE8300736D0 (sv) Novel pharmacologically active compounds
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
MA23608A1 (fr) Forme de dosage ii d'unite multiple en comprime
ATE128863T1 (de) Arzneimittelformulierungen mit verzögerter wirkstoffabgabe.
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
KR880010758A (ko) 서방성 제제
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
FR2698788B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
SE8804628D0 (sv) New compounds
HU9202044D0 (en) Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
GT199800196A (es) Combinaciones de estatina-eter carboxialquilico.
DE69321861D1 (de) 3-Aminochroman-Spiroderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ATE175870T1 (de) Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
DE69201368D1 (de) 1-(Alkoxybenzyl)piperazineamide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
ATE212543T1 (de) Pharmazeutische zusammensetzung aus stabilisierten lipophilen matrizen mit kontrollierter wirkstofffreisetzung
GR3018938T3 (en) 6-Oxopyridazine derivatives, process for their preparation and medicaments containing these compounds
EE9600202A (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm
ES2082523T3 (es) Un medicamento de accion retardada que contiene ibuprofen y su empleo.
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
ATE7911T1 (de) Pharmazeutisch zulassbare salze von 4'-(9acridinylamino)methansulfon-m-anisid, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
IL113816A0 (en) Pharmaceutical compositions containing desogestrel their preparation and use
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.
ATE4713T1 (de) 2-oxo-benzothiazolin-, benzoxazolin- oder indolin-derivate, deren herstellung und derartige verbindungen enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee